RT Generic
T1 SARS-COV-2 virus triggers immune antitumor response in a lymphoma patient
A1 Rudolphi-Solero, T.
A1 Rashki, M.
A1 Fernandez-Fernandez, J.
A1 Rivas-Navas, D.
A1 Ramos-Font, C.
A1 Rodriguez-Fernandez, A.
PB Elsevier espana slu
SN 2253-654X
YR 2023
FD 2023-01-17
LK https://hdl.handle.net/10668/26272
UL https://hdl.handle.net/10668/26272
LA en
DS RISalud
RD Apr 12, 2025